Peripheral blood mitochondrial DNA copy number as a predictor of steatotic liver disease development: insights from epidemiological and experimental studies
Environmental Health and Preventive Medicine · 2025
DOI: 10.1265/ehpm.25-00025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environmental Health and Preventive Medicine, 2025. Verfasst von Genki Mizuno und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Technology, Tokyo University of Technology School of Health Sciences. Hauptthemen laut MEDLINE: DNA, Mitochondrial, DNA Copy Number Variations, Fatty Liver. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND: Mitochondria, which harbor their own genome (mtDNA), have attracted attention due to the potential of mtDNA copy number (mtDNA-CN) as an indicator of mitochondrial dysfunction. Although mtDNA-CN has been proposed as a simple and accessible biomarker for metabolic disorders such as metabolic dysfunction-associated steatotic liver disease, the underlying mechanisms and the causal relationship remain insufficiently elucidated. In this investigation, we combined longitudinal epidemiological data, animal studies, and in vitro assays to elucidate the potential causal relationship between reduced mtDNA-CN and the development of steatotic liver disease (SLD). METHODS: We conducted a longitudinal study using data from a health examination cohort initiated in 1981 in Yakumo, Hokkaido, Japan. Data from examinations performed in 2015 and 2022 were analyzed, focusing on 76 subjects without SLD at baseline (2015) to assess the association between baseline mtDNA-CN and subsequent risk of SLD development. In addition, 28-day-old SD rats were fed ad libitum on a 45% high-fat diet and dissected at 2 and 8 weeks of age. Blood and liver mtDNA-CN were measured and compared at each feeding period. Additionally, in vitro experiments were performed using HepG2 cells treated with mitochondrial function inhibitors to induce mtDNA-CN depletion and to examine its impact on intracellular lipid accumulation. RESULTS: Epidemiological analysis showed that the subjects with low mtDNA-CN had a significantly higher odds ratio for developing SLD compared to high (odds ratio [95% confidence interval]: 4.93 [1.08-22.50]). Analysis of the animal model showed that 8 weeks of high-fat diet led to the development of fatty liver and a significant decrease in mtDNA-CN. A further 2 weeks of high-fat diet consumption resulted in a significant decrease in hepatic mtDNA-CN, despite the absence of fatty liver development, and a similar trend was observed for blood. Complementary in vitro experiments revealed that pharmacologically induced mitochondrial dysfunction led to a significant reduction in mtDNA-CN and was associated with increases in intracellular lipid accumulation in HepG2 cells. CONCLUSIONS: Our findings suggest that reduced mtDNA-CN may contribute causally to SLD development and could serve as a convenient, noninvasive biomarker for early detection and risk assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Technology, Tokyo University of Technology School of Health Sciences.
- Department of Preventive Medical Sciences, Fujita Health University School of Medical Sciences.
- Department of Joint Research Laboratory of Clinical Medicine, Fujita Health University Hospital.
- Department of Hygiene, Fujita Health University School of Medicine.
- Department of Animal Science and Biotechnology, Azabu University School of Veterinary Medicine.
- Department of Informative Clinical Medicine, Fujita Health University School of Medical Sciences.
Zitieren
APA
Mizuno, G., Teshigawara, A., Yamada, H., Munetsuna, E., Tsuboi, Y., Hattori, Y., Yamazaki, M., Ando, Y., Kageyama, I., Wakasugi, T., Ichino, N., Osakabe, K., Sugimoto, K., Fujii, R., Ishikawa, H., Ohgami, N., Ohashi, K., & Suzuki, K. (2025). Peripheral blood mitochondrial DNA copy number as a predictor of steatotic liver disease development: insights from epidemiological and experimental studies. Environmental Health and Preventive Medicine. https://doi.org/10.1265/ehpm.25-00025
Vancouver
Mizuno G, Teshigawara A, Yamada H, Munetsuna E, Tsuboi Y, Hattori Y, et al. Peripheral blood mitochondrial DNA copy number as a predictor of steatotic liver disease development: insights from epidemiological and experimental studies. Environmental Health and Preventive Medicine. 2025. doi:10.1265/ehpm.25-00025
BibTeX
@article{Mizuno2025,
author = {Mizuno, Genki and Teshigawara, Atsushi and Yamada, Hiroya and Munetsuna, Eiji and Tsuboi, Yoshiki and Hattori, Yuji and Yamazaki, Mirai and Ando, Yoshitaka and Kageyama, Itsuki and Wakasugi, Takuya and Ichino, Naohiro and Osakabe, Keisuke and Sugimoto, Keiko and Fujii, Ryosuke and Ishikawa, Hiroaki and Ohgami, Nobutaka and Ohashi, Koji and Suzuki, Koji},
title = {Peripheral blood mitochondrial DNA copy number as a predictor of steatotic liver disease development: insights from epidemiological and experimental studies},
journal = {Environmental Health and Preventive Medicine},
year = {2025},
doi = {10.1265/ehpm.25-00025}
}
EUVIMED